Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
ClinicalTrials.gov study NCT05312632. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
ClinicalTrials.gov study NCT01120184. IPD Sharing: Not stated. Countries: 38. Publications: 3.
Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants
ClinicalTrials.gov study NCT00859547. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors
ClinicalTrials.gov study NCT02407990. IPD Sharing: YES. Countries: 5. Publications: 2.
Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy
ClinicalTrials.gov study NCT01469013. IPD Sharing: YES. Countries: 1. Publications: 5.
Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies
ClinicalTrials.gov study NCT02795182. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study of CC-99677 in Participants With Active Ankylosing Spondylitis
ClinicalTrials.gov study NCT04947579. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression
ClinicalTrials.gov study NCT02422186. IPD Sharing: Not stated. Countries: 12. Publications: 3.
Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential Hypertension
ClinicalTrials.gov study NCT00696241. IPD Sharing: Not stated. Countries: 3. Publications: 2.
A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney
ClinicalTrials.gov study NCT03138512. IPD Sharing: NO. Countries: 25. Publications: 3.
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breas
ClinicalTrials.gov study NCT04622319. IPD Sharing: YES. Countries: 31. Publications: 1.
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheum
ClinicalTrials.gov study NCT03104400. IPD Sharing: YES. Countries: 46. Publications: 14.
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
ClinicalTrials.gov study NCT02795767. IPD Sharing: YES. Countries: 10. Publications: 2.
Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis
ClinicalTrials.gov study NCT01480076. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)
ClinicalTrials.gov study NCT01888874. IPD Sharing: Not stated. Countries: 22. Publications: 4.
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02111096. IPD Sharing: YES. Countries: 4. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine
ClinicalTrials.gov study NCT04152083. IPD Sharing: NO. Countries: 2. Publications: 4.
Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
ClinicalTrials.gov study NCT03967977. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma
ClinicalTrials.gov study NCT01910181. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)
ClinicalTrials.gov study NCT05070663. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.